Erratum: ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3 (Journal of Biological Chemistry(2020)295: 51(17887-17887)Doi: 10.1074/jbc.M111.284034);ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3

Journal of Biological Chemistry

Volumn 287, Issue 18, 2012, Pages 15001-15015

  Ghosh, Sonali ^a   Basu, Moitri ^a   Roy, Sib Sankar ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CHEMICAL ACTIVATION; DISEASES; GENE EXPRESSION; METALS; PATHOLOGY;

DOSE-DEPENDENT MANNER; EXTRACELLULAR MATRICES; MATRIX METALLOPROTEINASE-9; MATRIX METALLOPROTEINASES; NUCLEAR LOCALIZATION; OVARIAN CANCER CELLS; OVARIAN CARCINOMA CELL; VASCULAR ENDOTHELIAL GROWTH FACTOR;

CELL ENGINEERING;

COLLAGENASE 3; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ETS 1; VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ETS 1 GENE; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE LOCATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MARKER GENE; METASTASIS; MMP 13 GENE; MMP 9 GENE; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

EID: 84860377557     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.W120.016716     Document Type: Erratum

References (75)

1. Yap, T. A., Carden, C. P., and Kaye, S. B. (2009) Beyond chemotherapy: targeted therapies in ovarian cancer. Nat. Rev. Cancer 9, 167-181
2. Bérubé, M., Deschambeault, A., Boucher, M., Germain, L., Petitclerc, E., and Guérin, S. L. (2005) MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment. Mol. Vis. 11, 1101-1111
3. Sato, T., Sakai, T., Noguchi, Y., Takita, M., Hirakawa, S., and Ito, A. (2004) Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol. Oncol. 92, 47-56 (Pubitemid 38147370)
4. Di Nezza, L. A., Misajon, A., Zhang, J., Jobling, T., Quinn, M. A., Ostör, A. G., Nie, G., Lopata, A., and Salamonsen, L. A. (2002) Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 94, 1466-1475 (Pubitemid 34213290)
5. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., and Shafie, S. (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284, 67-68 (Pubitemid 10098769)
6. Stetler-Stevenson, W. G. (2001) The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg. Oncol. Clin. N. Am. 10, 383-392
7. Mitchell, P. G., Magna, H. A., Reeves, L. M., Lopresti-Morrow, L. L., Yocum, S. A., Rosner, P. J., Geoghegan, K. F., and Hambor, J. E. (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase- 13 from human osteoarthritic cartilage. J. Clin. Investig. 97, 761-768 (Pubitemid 26060542)
8. Yasuda, T., and Poole, A. R. (2002) A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Arthritis Rheum. 46, 138-148 (Pubitemid 34121660)
9. Brinckerhoff, C. E., Rutter, J. L., and Benbow, U. (2000) Interstitial collagenases as markers of tumor progression. Clin. Cancer Res. 6, 4823-4830 (Pubitemid 32110426)
10. Fingleton, B. (2008) MMPs as therapeutic targets - still a viable option? Semin. Cell Dev. Biol. 19, 61-68
11. Abu-Jawdeh, G. M., Faix, J. D., Niloff, J., Tognazzi, K., Manseau, E., Dvorak, H. F., and Brown, L. F. (1996) Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab. Invest. 74, 1105-1115 (Pubitemid 26184421)
12. Zhang, A., Meng, L., Wang, Q., Xi, L., Chen, G., Wang, S., Zhou, J., Lu, Y., and Ma, D. (2006) Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2. Oncol. Rep. 15, 831-836
13. Belotti, D., Paganoni, P., Manenti, L., Garofalo, A., Marchini, S., Taraboletti, G., and Giavazzi, R. (2003) Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res. 63, 5224-5229 (Pubitemid 37139832)
14. Sher, I., Adham, S. A., Petrik, J., and Coomber, B. L. (2009) Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis. Int. J. Cancer 124, 553-561
15. Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., and Sato, M. (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5, 519-524
16. Matthews, W., Jordan, C. T., Gavin, M., Jenkins, N. A., Copeland, N. G., and Lemischka, I. R. (1991) A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Natl. Acad. Sci. U.S.A. 88, 9026-9030 (Pubitemid 21915561)
17. Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P., Risau, W., and Ullrich, A. (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculo-genesis and angiogenesis. Cell 72, 835-846 (Pubitemid 23110226)
18. Terman, B. I., Carrion, M. E., Kovacs, E., Rasmussen, B. A., Eddy, R. L., and Shows, T. B. (1991) Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6, 1677-1683 (Pubitemid 21924273)
19. Pajusola, K., Aprelikova, O., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, R., and Alitalo, K. (1992) FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res. 52, 5738-5743
20. Ferrara, N. (1999) Vascular endothelial growth factor: molecular and biological aspects. Curr. Top. Microbiol. Immunol. 237, 1-30
21. Shibuya, M. (2006) Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J. Biochem. Mol. Biol. 39, 469-478
22. Ghosh, S., and Maity, P. (2010) VEGF antibody plus cisplatin reduces angiogenesis and tumor growth in a xenograft model of ovarian cancer. J. Environ. Pathol. Toxicol. Oncol. 29, 17-30
23. Ramakrishnan, S., Olson, T. A., Bautch, V. L., and Mohanraj, D. (1996) Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo. Cancer Res. 56, 1324-1330 (Pubitemid 26084349)
24. Wang, F. Q., So, J., Reierstad, S., and Fishman, D. A. (2006) Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases. Int. J. Cancer 118, 879-888 (Pubitemid 43157663)
25. Belotti, D., Calcagno, C., Garofalo, A., Caronia, D., Riccardi, E., Giavazzi, R., and Taraboletti, G. (2008) Vascular endothelial growth factor stimulates organ-specific host matrix metalloproteinase-9 expression and ovarian cancer invasion. Mol. Cancer Res. 6, 525-534 (Pubitemid 351521834)
26. Keshet, Y., and Seger, R. (2010) The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions. Methods Mol. Biol. 661, 3-38
27. Martelli, A. M., Evangelisti, C., Chiarini, F., Grimaldi, C., Cappellini, A., Ognibene, A., and McCubrey, J. A. (2010) The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. Biochim. Biophys. Acta 1803, 991-1002
28. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B. E., Karandikar, M., Berman, K., and Cobb, M. H. (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22, 153-183 (Pubitemid 32458157)
29. Suarez-Cuervo, C., Merrell, M. A., Watson, L., Harris, K. W., Rosenthal, E. L., Väänänen, H. K., and Selander, K. S. (2004) Breast cancer cells with inhibition of p38α have decreased MMP-9 activity and exhibit decreased bone metastasis in mice. Clin. Exp. Metastasis 21, 525-533
30. Tsuchiya, T., Tsuno, N. H., Asakage, M., Yamada, J., Yoneyama, S., Okaji, Y., Sasaki, S., Kitayama, J., Osada, T., Takahashi, K., and Nagawa, H. (2008) Apoptosis induction by p38 MAPK inhibitor in human colon cancer cells. Hepatogastroenterology 55, 930-935 (Pubitemid 351975958)
31. Menakongka, A., and Suthiphongchai, T. (2010) Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion. World J. Gastroenterol. 16, 713-722
32. Zhou, H. Y., Wan, K. F., Ip, C. K., Wong, C. K., Mak, N. K., Lo, K. W., and Wong, A. S. (2008) Hepatocyte growth factor enhances proteolysis and invasiveness of human nasopharyngeal cancer cells through activation of PI3K and JNK. FEBS Lett. 582, 3415-3422
33. Matsuoka, H., Tsubaki, M., Yamazoe, Y., Ogaki, M., Satou, T., Itoh, T., Kusunoki, T., and Nishida, S. (2009) Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/ MEK/ERK and PKC/PI3K/Akt pathways. Exp. Cell Res. 315, 2022-2032
34. Weng, C. J., Chau, C. F., Hsieh, Y. S., Yang, S. F., and Yen, G. C. (2008) Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-κB and AP-1. Carcinogenesis 29, 147-156
35. Rabinovich, A., Medina, L., Piura, B., Segal, S., and Huleihel, M. (2007) Regulation of ovarian carcinoma SKOV-3 cell proliferation and secretion of MMPs by autocrine IL-6. Anticancer Res. 27, 267-272 (Pubitemid 46363341)
36. Liao, X., Siu, M. K., Au, C. W., Wong, E. S., Chan, H. Y., Ip, P. P., Ngan, H. Y., and Cheung, A. N. (2009) Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis 30, 131-140
37. Repici, M., Mare, L., Colombo, A., Ploia, C., Sclip, A., Bonny, C., Nicod, P., Salmona, M., and Borsello, T. (2009) c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons. Neuroscience 159, 94-103
38. Sementchenko, V. I., and Watson, D. K. (2000) Ets target genes: past, present and future. Oncogene 19, 6533-6548 (Pubitemid 32108443)
39. Overall, C. M., and López-Otín, C. (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer 2, 657-672 (Pubitemid 37328917)
40. Rundhaug, J. E. (2005) Matrix metalloproteinases and angiogenesis. J. Cell. Mol. Med. 9, 267-285
41. Oettgen, P. (2010) The role of ets factors in tumor angiogenesis. J. Oncol. 2010, 767384
42. Alipov, G., Nakayama, T., Ito, M., Kawai, K., Naito, S., Nakashima, M., Niino, D., and Sekine, I. (2005) Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas. Histopathology 46, 202-208 (Pubitemid 40293019)
43. Chang, X. Z., Yu, J., Zhang, X. H., Yin, J., Wang, T., and Cao, X. C. (2009) Enhanced expression of trophinin promotes invasive and metastatic potential of human gallbladder cancer cells. J. Cancer Res. Clin. Oncol. 135, 581-590
44. Buggy, Y., Maguire, T. M., McGreal, G., McDermott, E., Hill, A. D., O'Higgins, N., and Duffy, M. J. (2004) Overexpression of the Ets-1 transcription factor in human breast cancer. Br. J. Cancer 91, 1308-1315 (Pubitemid 39424792)
45. Sasaki, H., Yukiue, H., Moiriyama, S., Kobayashi, Y., Nakashima, Y., Kaji, M., Kiriyama, M., Fukai, I., Yamakawa, Y., and Fujii, Y. (2001) Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. J. Surg. Res. 101, 242-247 (Pubitemid 34044566)
46. Saeki, H., Oda, S., Kawaguchi, H., Ohno, S., Kuwano, H., Maehara, Y., and Sugimachi, K. (2002) Concurrent overexpression of Ets-1 and c-Met correlates with a phenotype of high cellular motility in human esophageal cancer. Int. J. Cancer 98, 8-13 (Pubitemid 34113410)
47. Xu, D., Dwyer, J., Li, H., Duan, W., and Liu, J. P. (2008) Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc. J. Biol. Chem. 283, 23567-23580
48. Baker, R., Kent, C. V., Silbermann, R. A., Hassell, J. A., Young, L. J., and Howe, L. R. (2010) Pea3 transcription factors and wnt1-induced mouse mammary neoplasia. PLoS One 5, e8854
49. Boocock, C. A., Charnock-Jones, D. S., Sharkey, A. M., McLaren, J., Barker, P. J., Wright, K. A., Twentyman, P. R., and Smith, S. K. (1995) Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J. Natl. Cancer Inst. 87, 506-516
50. Wang, J. Y., Sun, T., Zhao, X. L., Zhang, S. W., Zhang, D. F., Gu, Q., Wang, X. H., Zhao, N., Qie, S., and Sun, B. C. (2008) Functional significance of VEGF-a in human ovarian carcinoma: role in vasculogenic mimicry. Cancer Biol. Ther. 7, 758-766
51. Stoker, M., Gherardi, E., Perryman, M., and Gray, J. (1987) Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327, 239-242 (Pubitemid 17071053)
52. Saha, S. K., Ghosh, P., Konar, A., Bhattacharya, S., and Roy, S. S. (2005) Differential expression of procollagen lysine 2-oxoglutarate 5-deoxygenase and matrix metalloproteinase isoforms in hypothyroid rat ovary and disintegration of extracellular matrix. Endocrinology 146, 2963-2975 (Pubitemid 41002803)
53. Giulietti, A., Overbergh, L., Valckx, D., Decallonne, B., Bouillon, R., and Mathieu, C. (2001) An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25, 386-401 (Pubitemid 34164011)
54. Ghosh, S., and Maity, P. (2007) Augmented antitumor effects of combination therapy with VEGF antibody and cisplatin on murine B16F10 melanoma cells. Int. Immunopharmacol. 7, 1598-1608 (Pubitemid 350054926)
55. Saha, S., Ghosh, P., Mitra, D., Mukherjee, S., Bhattacharya, S., and Roy, S. S. (2007) Localization and thyroid hormone influenced expression of collagen II in ovarian tissue. Cell. Physiol. Biochem. 19, 67-76
56. Nakamura, Y., Esnault, S., Maeda, T., Kelly, E. A., Malter, J. S., and Jarjour, N. N. (2004) Ets-1 regulates TNF-α-induced matrix metalloproteinase-9 and tenascin expression in primary bronchial fibroblasts. J. Immunol. 172, 1945-1952 (Pubitemid 38116845)
57. Radjabi, A. R., Sawada, K., Jagadeeswaran, S., Eichbichler, A., Kenny, H. A., Montag, A., Bruno, K., and Lengyel, E. (2008) Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase- 9 and β1-integrin on the cell surface. J. Biol. Chem. 283, 2822-2834
58. Gum, R., Lengyel, E., Juarez, J., Chen, J. H., Sato, H., Seiki, M., and Boyd, D. (1996) Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen- activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem. 271, 10672-10680
59. Yu, J. Y., DeRuiter, S. L., and Turner, D. L. (2002) RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99, 6047-6052 (Pubitemid 34493262)
60. Page-McCaw, A., Ewald, A. J., and Werb, Z. (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8, 221-233
61. Kessenbrock, K., Plaks, V., and Werb, Z. (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67
62. Gialeli, C., Theocharis, A. D., and Karamanos, N. K. (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 278, 16-27
63. Iozzo, R. V., Zoeller, J. J., and Nyström, A. (2009) Basement membrane proteoglycans: modulators par excellence of cancer growth and angiogenesis. Mol. Cells 27, 503-513
64. Zhou, H. Y., and Wong, A. S. (2006) Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells. Endocrinology 147, 2557-2566
65. Riesterer, O., Zingg, D., Hummerjohann, J., Bodis, S., and Pruschy, M. (2004) Degradation of PKB/Akt protein by inhibition of the VEGF receptor/ mTOR pathway in endothelial cells. Oncogene 23, 4624-4635 (Pubitemid 38850410)
66. Park, B. K., Zeng, X., and Glazer, R. I. (2001) Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. Cancer Res. 61, 7647-7653 (Pubitemid 32995061)
67. Kumar, S., Bryant, C. S., Chamala, S., Qazi, A., Seward, S., Pal, J., Steffes, C. P., Weaver, D. W., Morris, R., Malone, J. M., Shammas, M. A., Prasad, M., and Batchu, R. B. (2009) Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells. Mol. Cancer 8, 26
68. Sahin, A., Velten, M., Pietsch, T., Knuefermann, P., Okuducu, A. F., Hahne, J. C., and Wernert, N. (2005) Inactivation of Ets 1 transcription factor by a specific decoy strategy reduces rat C6 glioma cell proliferation and mmp-9 expression. Int. J. Mol. Med. 15, 771-776
69. Nagarajan, P., Parikh, N., Garrett-Sinha, L. A., and Sinha, S. (2009) Ets1 induces dysplastic changes when expressed in terminally-differentiating squamous epidermal cells. PLoS One 4, e4179
70. Yokota, H., Goldring, M. B., and Sun, H. B. (2003) CITED2-mediated regulation of MMP-1 and MMP-13 in human chondrocytes under flow shear. J. Biol. Chem. 278, 47275-47280 (Pubitemid 37452316)
71. Schröpfer, A., Kammerer, U., Kapp, M., Dietl, J., Feix, S., and Anacker, J. (2010) Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines. BMC Cancer 10, 553-564
72. Simon, C., Simon, M., Vucelic, G., Hicks, M. J., Plinkert, P. K., Koitschev, A., and Zenner, H. P. (2001) The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp. Cell Res. 271, 344-355 (Pubitemid 33141216)
73. Song, H., Ki, S. H., Kim, S. G., and Moon, A. (2006) Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res. 66, 10487-10496 (Pubitemid 44799770)
74. Boulukos, K. E., Pognonec, P., Rabault, B., Begue, A., and Ghysdael, J. (1989) Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro. Mol. Cell. Biol. 9, 5718-5721 (Pubitemid 20004392)
75. 2+/calmodulin- dependent protein kinase II in osteoblastic cells. J. Mol. Endocrinol. 25, 73-84